President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...

Clinicians should not neglect proteinuria testing in adults younger than age 40 years to identify those at high risk for sudden cardiac arrest.

While Stephen Lambert flew an L-39 Albatross in May of 2024, lifelong friend Greg Scohy was in the backseat enjoying the ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

Comparison of eGFR change rates before and after renal internal medical referral. Before the referral (left orange), the ...

Among patients with diabetes receiving PCI, novel antidiabetic agents may reduce risk for acute kidney injury.

Learn about the 4 essential types of diabetes, their unique characteristics, risk factors, and management strategies to ...

An invaluable resource is being starved to death with no scientific or ethical justification ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...